Globe Life Inc. $GL Shares Purchased by Arbejdsmarkedets Tillaegspension

Arbejdsmarkedets Tillaegspension grew its stake in shares of Globe Life Inc. (NYSE:GL) by 4.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 182,830 shares of the company’s stock after purchasing an additional 8,069 shares during the quarter. Arbejdsmarkedets Tillaegspension’s holdings in Globe Life were worth $25,444,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. SG Americas Securities LLC grew its holdings in shares of Globe Life by 909.6% during the fourth quarter. SG Americas Securities LLC now owns 99,746 shares of the company’s stock worth $13,950,000 after purchasing an additional 89,866 shares during the last quarter. Tudor Investment Corp ET AL purchased a new stake in Globe Life in the third quarter valued at approximately $7,348,000. JPMorgan Chase & Co. lifted its stake in Globe Life by 11.1% in the third quarter. JPMorgan Chase & Co. now owns 247,947 shares of the company’s stock valued at $35,449,000 after buying an additional 24,785 shares during the last quarter. Capitolis Liquid Global Markets LLC acquired a new stake in shares of Globe Life in the third quarter valued at approximately $5,862,000. Finally, Vanguard Group Inc. grew its position in Globe Life by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after purchasing an additional 86,349 shares during the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Michael Clay Majors sold 34,000 shares of the business’s stock in a transaction dated Friday, April 24th. The shares were sold at an average price of $153.81, for a total value of $5,229,540.00. Following the completion of the transaction, the executive vice president owned 53,518 shares of the company’s stock, valued at approximately $8,231,603.58. The trade was a 38.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Thomas Peter Kalmbach sold 7,936 shares of the firm’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.59, for a total transaction of $1,242,698.24. Following the sale, the chief financial officer directly owned 50,496 shares in the company, valued at $7,907,168.64. This represents a 13.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 124,187 shares of company stock valued at $19,529,414. Corporate insiders own 2.11% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on GL. Keefe, Bruyette & Woods restated a “moderate buy” rating and issued a $168.00 price target on shares of Globe Life in a research report on Thursday, March 26th. Morgan Stanley increased their price target on Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a report on Monday, July 6th. Texas Capital upgraded shares of Globe Life to a “strong-buy” rating in a research note on Wednesday, March 18th. TD Cowen increased their price target on shares of Globe Life from $199.00 to $215.00 and gave the stock a “buy” rating in a report on Tuesday, June 23rd. Finally, Wells Fargo & Company lifted their price objective on Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $179.70.

Globe Life Price Performance

Shares of NYSE:GL opened at $179.10 on Monday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. The firm has a market capitalization of $13.91 billion, a price-to-earnings ratio of 12.39 and a beta of 0.47. Globe Life Inc. has a 12 month low of $117.30 and a 12 month high of $182.32. The business’s 50 day simple moving average is $163.71 and its 200-day simple moving average is $150.24.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.46 by ($0.03). The firm had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The company’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same period last year, the firm earned $3.07 EPS. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, equities analysts forecast that Globe Life Inc. will post 15.64 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio is 9.13%.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.